Health And Pharma

Magnetic Nanoparticle-Guided Hyperthermia Opens a New Path for Advanced Solid Tumors

Mayo Clinic has launched the first U.S. clinical research program using magnetic nanoparticle-mediated hyperthermia for ...
Health And Pharma

Sunvozertinib Outperforms Chemotherapy in First-Line EGFR Exon 20 Insertion NSC Lung Cancer

Phase 3 WU-KONG28 trial met its primary endpoint, showing that once-daily oral sunvozertinib significantly improved ...
Health And Pharma

FDA Approves Nivolumab-AVD as First Immunotherapy Combination for Hodgkin Lymphoma

The FDA has approved nivolumab (Opdivo) plus AVD as first-line treatment for advanced classical Hodgkin lymphoma in patients ...
Health And Pharma

TG Therapeutics Secures $500M to Advance BRIUMVI in Relapsing Multiple Sclerosis

TG Therapeutics secured $500 million in non-dilutive capital through a new credit facility, supporting the expansion of ...
Health And Pharma

Phase 3 TALAPRO-3 Supports Early Use of Talazoparib in HRR-Mutated mCS Prostate Cancer

Phase 3 TALAPRO-3 results show that talazoparib plus enzalutamide significantly improves radiographic progression-free ...